Aster Capital Management (DIFC) Ltd
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 2040915
DUBAI, C0
Position in BIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$98,677
+$93,630 QoQ
Shares Held
354
+1866.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aster Capital Management (DIFC) Ltd holds $5,163,602 across 16 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
29,970 | $2,344,553 | |
| 2 | BSX |
Boston Scientific Corp
|
15,672 | $668,880 | |
| 3 | LAB |
Standard Biotools Inc.
|
541,130 | $443,726 | |
| 4 | PODD |
Insulet Corp
|
2,801 | $426,452 | |
| 5 | TMCI |
Treace Medical Concepts, Inc.
|
91,740 | $365,125 | |
| 6 | QSI |
Quantum-Si Inc
|
344,510 | $304,891 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,256 | $208,416 | |
| 8 | MXCT |
Maxcyte, Inc.
|
163,270 | $200,822 |
All Filings in BIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,677 | 354 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $5,047 | 18 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $71,672 | 297 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $594,773 | 2,442 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $35,465 | 106 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||